Becton Dickinson's diagnostics sales up 4% in fiscal 1996
This article was originally published in Clinica
Executive Summary
Becton Dickinson's diagnostic systems revenue rose 4% to $1,260 million in 1996 with a strong performance by its flow cytometry and sample collection businesses. The company's infectious disease diagnostics sector continues to suffer from a reduction in testing.